Global X Genomics & Biotechnology ETF Rating → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free GNOM Stock Alerts $10.96 +0.15 (+1.39%) (As of 11:44 AM ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy2.64Holdings in GNOM have an aggregate rating of Moderate Buy based on 421 analyst ratings issued in the past year covering 39 companies (97.3% of the portfolio).GNOM Aggregate Price Target$16.9754.87% UpsideHigh Prediction$26.51Average Prediction$16.97Low Prediction$10.08Holdings in GNOM have an aggregate price target of $16.97 and a range of $10.08 to $26.51 covering 39 companies (97.3% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy26 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 GNOM Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.33%NTRANatera$106.86+1.3%1 of 5 stars3.00$98.47 -7.9%15Earnings ReportAnalyst Forecast5.54%MRNAModerna$126.17-1.7%3 of 5 stars2.24$126.46 0.2%17Analyst Forecast4.82%AAgilent Technologies$153.54+1.5%4 of 5 stars2.59$141.29 -8.0%17Short Interest ↑Analyst Revision4.74%CRSPCRISPR Therapeutics$56.58+1.6%3 of 5 stars2.35$73.93 30.7%17Earnings ReportAnalyst RevisionGap Up4.42%RAREUltragenyx Pharmaceutical$41.25+0.7%4 of 5 stars2.92$87.85 113.0%124.39%TECHBio-Techne$83.11-1.2%4 of 5 stars2.82$80.50 -3.1%11Positive News4.31%SRPTSarepta Therapeutics$133.88+0.9%4 of 5 stars2.86$161.81 20.9%14Analyst Upgrade3.94%QGENQiagen$45.68+0.6%4 of 5 stars2.56$50.95 11.5%93.68%MYGNMyriad Genetics$25.20-0.6%2 of 5 stars2.50$25.57 1.5%8Analyst Forecast3.66%ARWRArrowhead Pharmaceuticals$25.18+9.9%4 of 5 stars2.78$51.00 102.5%9Earnings ReportAnalyst ForecastShort Interest ↑Analyst Revision3.62%RNAAvidity Biosciences$30.25+4.6%1 of 5 stars3.00$38.29 26.6%73.49%BMRNBioMarin Pharmaceutical$80.56+1.1%5 of 5 stars2.65$107.79 33.8%20Analyst ForecastInsider SellingShort Interest ↑Analyst Revision3.38%ILMNIllumina$113.87-1.5%5 of 5 stars2.30$164.65 44.6%20Short Interest ↓Gap Up3.34%RCKTRocket Pharmaceuticals$24.08+3.0%5 of 5 stars2.89$52.13 116.5%9Gap Up3.33%ALNYAlnylam Pharmaceuticals$148.48+0.4%4 of 5 stars2.59$216.19 45.6%17Short Interest ↑3.30%BNTXBioNTech$92.49+0.2%2 of 5 stars2.27$117.25 26.8%11Analyst ForecastShort Interest ↑Analyst Revision3.29%NTLAIntellia Therapeutics$26.31+2.3%4 of 5 stars2.69$66.77 153.8%13Gap Up2.90%BEAMBeam Therapeutics$24.58+3.2%1 of 5 stars2.38$40.18 63.5%13Short Interest ↑Analyst RevisionGap Up2.82%VCYTVeracyte$23.60+2.5%3 of 5 stars2.60$27.50 16.5%5Short Interest ↑Gap Up2.49%LEGNLegend Biotech$45.38+2.3%2 of 5 stars2.92$82.64 82.1%12Earnings ReportAnalyst ForecastShort Interest ↑News Coverage2.39%TXG10x Genomics$26.49-0.3%5 of 5 stars2.58$48.50 83.1%12Gap Up2.01%VRTXVertex Pharmaceuticals$434.91+1.5%4 of 5 stars2.48$432.18 -0.6%251.82%SANASana Biotechnology$9.02+4.9%2 of 5 stars2.75$11.67 29.3%4Gap Up1.62%VIRVir Biotechnology$9.99-0.9%2 of 5 stars2.57$33.57 236.1%7Gap Up1.44%GILDGilead Sciences$67.38-0.4%5 of 5 stars2.39$83.69 24.2%18Analyst Revision1.29%RGNXREGENXBIO$16.41+3.9%4 of 5 stars2.83$38.45 134.3%12Earnings ReportAnalyst RevisionGap Up1.03%CDNACareDx$14.77-3.1%2 of 5 stars2.60$14.75 -0.1%5Analyst ForecastShort Interest ↑News CoverageGap Up0.79%EDITEditas Medicine$6.09+7.2%4 of 5 stars2.50$13.90 128.2%10Earnings ReportInsider BuyingShort Interest ↑Analyst RevisionGap Up0.79%FLGTFulgent Genetics$22.51+0.9%4 of 5 stars2.00$30.00 33.3%2Short Interest ↑0.79%PACBPacific Biosciences of California$2.11-5.6%3 of 5 stars2.53$7.14 239.0%15Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up0.59%LYELLyell Immunopharma$2.62+3.1%1 of 5 stars2.50$5.50 109.9%2Short Interest ↑Gap Up0.57%ALLOAllogene Therapeutics$3.10+4.7%1 of 5 stars2.63$12.23 294.5%8Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoverageGap Up0.52%CRBUCaribou Biosciences$3.70+1.6%2 of 5 stars2.75$22.50 508.1%4Analyst ForecastShort Interest ↓Gap Up0.51%VERVVerve Therapeutics$6.38+2.4%3 of 5 stars2.75$33.00 417.2%8Earnings ReportAnalyst RevisionGap Up0.40%QUREuniQure$5.04+2.6%2 of 5 stars2.71$26.67 429.1%7Analyst Revision0.39%TSVT2seventy bio$4.91+3.8%2 of 5 stars2.60$12.86 161.9%10Analyst Revision0.34%PSTXPoseida Therapeutics$3.39+16.1%4 of 5 stars3.00$14.67 332.6%3Short Interest ↑0.20%BLUEbluebird bio$1.11+3.3%2 of 5 stars2.27$5.74 419.9%11Gap Up0.05%SCLXScilex$0.82+2.4%2 of 5 stars3.00$6.00 632.4%2News CoverageGap Up This page (NASDAQ:GNOM) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
